MCL-1 is essential for survival but dispensable for metabolic fitness of FOXP3
Animals
Apoptosis
/ genetics
Cell Survival
/ genetics
Female
Forkhead Transcription Factors
/ genetics
Gene Deletion
Homeostasis
/ immunology
Immune Tolerance
Male
Mice
Mice, Inbred C57BL
Mice, Knockout
Myeloid Cell Leukemia Sequence 1 Protein
/ genetics
Signal Transduction
T-Lymphocytes, Regulatory
/ immunology
Journal
Cell death and differentiation
ISSN: 1476-5403
Titre abrégé: Cell Death Differ
Pays: England
ID NLM: 9437445
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
received:
18
11
2019
accepted:
22
06
2020
revised:
18
06
2020
pubmed:
3
7
2020
medline:
15
12
2021
entrez:
3
7
2020
Statut:
ppublish
Résumé
FOXP3
Identifiants
pubmed: 32612106
doi: 10.1038/s41418-020-0585-1
pii: 10.1038/s41418-020-0585-1
pmc: PMC7853142
doi:
Substances chimiques
Forkhead Transcription Factors
0
Foxp3 protein, mouse
0
Mcl1 protein, mouse
0
Myeloid Cell Leukemia Sequence 1 Protein
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3374-3385Références
Strasser A, O’Connor L, Dixit VM. Apoptosis signaling. Annu Rev Biochem. 2000;69:217–45.
pubmed: 10966458
doi: 10.1146/annurev.biochem.69.1.217
pmcid: 10966458
Delbridge AR, Strasser A. The BCL-2 protein family, BH3-mimetics and cancer therapy. Cell Death Differ. 2015;22:1071–80.
pubmed: 25952548
pmcid: 4572872
doi: 10.1038/cdd.2015.50
Meier P, Finch A, Evan G. Apoptosis in development. Nature. 2000;407:796–801.
pubmed: 11048731
doi: 10.1038/35037734
Vo TT, Letai A. BH3-only proteins and their effects on cancer. Adv Exp Med Biol. 2010;687:49–63.
pubmed: 20919637
pmcid: 3733261
doi: 10.1007/978-1-4419-6706-0_3
Doerflinger M, Glab JA, Puthalakath H. BH3-only proteins: a 20-year stock-take. FEBS J. 2015;282:1006–16.
pubmed: 25565426
doi: 10.1111/febs.13190
Adams JM, Cory S. The BCL-2 arbiters of apoptosis and their growing role as cancer targets. Cell Death Differ. 2018;25:27–36.
pubmed: 29099483
doi: 10.1038/cdd.2017.161
Josefowicz SZ, Lu LF, Rudensky AY. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol. 2012;30:531–64.
pubmed: 22224781
pmcid: 6066374
doi: 10.1146/annurev.immunol.25.022106.141623
Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 2003;4:330–6.
pubmed: 12612578
doi: 10.1038/ni904
Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995;155:1151–64.
pubmed: 7636184
Liston A, Gray DH. Homeostatic control of regulatory T cell diversity. Nat Rev Immunol. 2014;14:154–65.
pubmed: 24481337
doi: 10.1038/nri3605
pmcid: 24481337
Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet. 2001;27:20–21.
pubmed: 11137993
doi: 10.1038/83713
pmcid: 11137993
Bennett CL, Ochs HD. IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomena. Curr Opin Pediatr. 2001;13:533–8.
pubmed: 11753102
doi: 10.1097/00008480-200112000-00007
pmcid: 11753102
Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, Buist N, et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet. 2001;27:18–20.
pubmed: 11137992
doi: 10.1038/83707
pmcid: 11137992
Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057–61.
pubmed: 12522256
doi: 10.1126/science.1079490
pmcid: 12522256
Khattri R, Cox T, Yasayko SA, Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol. 2003;4:337–42.
pubmed: 12612581
doi: 10.1038/ni909
pmcid: 12612581
Attias M, Al-Aubodah T, Piccirillo CA. Mechanisms of human FoxP3(+) Treg cell development and function in health and disease. Clin Exp Immunol. 2019;197:36–51.
pubmed: 30864147
pmcid: 6591147
Mathis D. Immunological goings-on in visceral adipose tissue. Cell Metab. 2013;17:851–9.
pubmed: 23747244
pmcid: 4264591
doi: 10.1016/j.cmet.2013.05.008
Passerini L, Bacchetta R. Forkhead-box-P3 gene transfer in human CD4(+) T conventional cells for the generation of stable and efficient regulatory T cells, suitable for immune modulatory therapy. Front Immunol. 2017;8:1282.
pubmed: 29075264
pmcid: 5643480
doi: 10.3389/fimmu.2017.01282
Perdigoto AL, Chatenoud L, Bluestone JA, Herold KC. Inducing and administering Tregs to treat human disease. Front Immunol. 2015;6:654.
pubmed: 26834735
pmcid: 26834735
Zhang D, Tu E, Kasagi S, Zanvit P, Chen Q, Chen W. Manipulating regulatory T cells: a promising strategy to treat autoimmunity. Immunotherapy. 2015;7:1201–11.
pubmed: 26568117
pmcid: 4976828
doi: 10.2217/imt.15.79
Passerini L, Rossi Mel E, Sartirana C, Fousteri G, Bondanza A, Naldini L, et al. CD4(+) T cells from IPEX patients convert into functional and stable regulatory T cells by FOXP3 gene transfer. Sci Transl Med. 2013;5:215ra174.
pubmed: 24337481
doi: 10.1126/scitranslmed.3007320
Pierson W, Cauwe B, Policheni A, Schlenner SM, Franckaert D, Berges J, et al. Antiapoptotic Mcl-1 is critical for the survival and niche-filling capacity of Foxp3(+) regulatory T cells. Nat Immunol. 2013;14:959–65.
pubmed: 23852275
pmcid: 4128388
doi: 10.1038/ni.2649
Carrington EM, Zhan Y, Brady JL, Zhang JG, Sutherland RM, Anstee NS, et al. Anti-apoptotic proteins BCL-2, MCL-1 and A1 summate collectively to maintain survival of immune cell populations both in vitro and in vivo. Cell Death Differ. 2017;24:878–88.
pubmed: 28362427
pmcid: 5423112
doi: 10.1038/cdd.2017.30
Kotschy A, Szlavik Z, Murray J, Davidson J, Maragno AL, Le Toumelin-Braizat G, et al. The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models. Nature. 2016;538:477–82.
doi: 10.1038/nature19830
Merino D, Whittle JR, Vaillant F, Serrano A, Gong JN, Giner G, et al. Synergistic action of the MCL-1 inhibitor S63845 with current therapies in preclinical models of triple-negative and HER2-amplified breast cancer. Sci Transl Med. 2017;9:eaam7049.
pubmed: 28768804
doi: 10.1126/scitranslmed.aam7049
Weeden CE, Ah-Cann C, Holik AZ, Pasquet J, Garnier JM, Merino D, et al. Dual inhibition of BCL-XL and MCL-1 is required to induce tumour regression in lung squamous cell carcinomas sensitive to FGFR inhibition. Oncogene. 2018;37:4475–88.
pubmed: 29743589
doi: 10.1038/s41388-018-0268-2
Brennan MS, Chang C, Tai L, Lessene G, Strasser A, Dewson G, et al. Humanized Mcl-1 mice enable accurate preclinical evaluation of MCL-1 inhibitors destined for clinical use. Blood. 2018;132:1573–83.
pubmed: 30139826
doi: 10.1182/blood-2018-06-859405
Caenepeel S, Brown SP, Belmontes B, Moody G, Keegan KS, Chui D, et al. AMG 176, a selective MCL1 inhibitor, is effective in hematologic cancer models alone and in combination with established therapies. Cancer Discov. 2018;8:1582–97.
pubmed: 30254093
Perciavalle RM, Stewart DP, Koss B, Lynch J, Milasta S, Bathina M, et al. Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration. Nat Cell Biol. 2012;14:575–83.
pubmed: 22544066
pmcid: 3401947
doi: 10.1038/ncb2488
Wang X, Bathina M, Lynch J, Koss B, Calabrese C, Frase S, et al. Deletion of MCL-1 causes lethal cardiac failure and mitochondrial dysfunction. Genes Dev. 2013;27:1351–64.
pubmed: 23788622
pmcid: 3701191
doi: 10.1101/gad.215855.113
Rasmussen ML, Kline LA, Park KP, Ortolano NA, Romero-Morales AI, Anthony CC, et al. A non-apoptotic function of MCL-1 in promoting pluripotency and modulating mitochondrial dynamics in stem cells. Stem Cell Rep. 2018;10:684–92.
doi: 10.1016/j.stemcr.2018.01.005
Rasmussen ML, Taneja N, Neininger AC, Wang L, Robertson GL, Riffle SN, et al. MCL-1 inhibition by selective BH3 mimetics disrupts mitochondrial dynamics causing loss of viability and functionality of human cardiomyocytes. iScience. 2020;23:101015.
pubmed: 32283523
pmcid: 7155208
doi: 10.1016/j.isci.2020.101015
Zeng H, Yang K, Cloer C, Neale G, Vogel P, Chi H. mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function. Nature. 2013;499:485–90.
pubmed: 23812589
pmcid: 3759242
doi: 10.1038/nature12297
Vikstrom I, Carotta S, Luthje K, Peperzak V, Jost PJ, Glaser S, et al. Mcl-1 is essential for germinal center formation and B cell memory. Science. 2010;330:1095–9.
pubmed: 20929728
pmcid: 2991396
doi: 10.1126/science.1191793
Rubtsov YP, Rasmussen JP, Chi EY, Fontenot J, Castelli L, Ye X, et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity. 2008;28:546–58.
pubmed: 18387831
doi: 10.1016/j.immuni.2008.02.017
pmcid: 18387831
Godfrey VL, Wilkinson JE, Rinchik EM, Russell LB. Fatal lymphoreticular disease in the scurfy (sf) mouse requires T cells that mature in a sf thymic environment: potential model for thymic education. Proc Natl Acad Sci USA. 1991;88:5528–32.
pubmed: 2062835
doi: 10.1073/pnas.88.13.5528
pmcid: 2062835
Godfrey VL, Wilkinson JE, Russell LB. X-linked lymphoreticular disease in the scurfy (sf) mutant mouse. Am J Pathol. 1991;138:1379–87.
pubmed: 2053595
pmcid: 1886400
Takeuchi O, Fisher J, Suh H, Harada H, Malynn BA, Korsmeyer SJ. Essential role of BAX,BAK in B cell homeostasis and prevention of autoimmune disease. Proc Natl Acad Sci USA. 2005;102:11272–7.
pubmed: 16055554
doi: 10.1073/pnas.0504783102
pmcid: 16055554
Willis SN, Chen L, Dewson G, Wei A, Naik E, Fletcher JI, et al. Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev. 2005;19:1294–305.
pubmed: 15901672
pmcid: 1142553
doi: 10.1101/gad.1304105
Zhai D, Jin C, Huang Z, Satterthwait AC, Reed JC. Differential regulation of Bax and Bak by anti-apoptotic Bcl-2 family proteins Bcl-B and Mcl-1. J Biol Chem. 2008;283:9580–6.
pubmed: 18178565
pmcid: 2442277
doi: 10.1074/jbc.M708426200
Wali JA, Galic S, Tan CY, Gurzov EN, Frazier AE, Connor T, et al. Loss of BIM increases mitochondrial oxygen consumption and lipid oxidation, reduces adiposity and improves insulin sensitivity in mice. Cell Death Differ. 2018;25:217–25.
pubmed: 29053141
doi: 10.1038/cdd.2017.168
Tripathi P, Koss B, Opferman JT, Hildeman DA. Mcl-1 antagonizes Bax/Bak to promote effector CD4(+) and CD8(+) T-cell responses. Cell Death Differ. 2013;20:998–1007.
pubmed: 23558951
pmcid: 3705594
doi: 10.1038/cdd.2013.25
Beier UH, Angelin A, Akimova T, Wang L, Liu Y, Xiao H, et al. Essential role of mitochondrial energy metabolism in Foxp3(+) T-regulatory cell function and allograft survival. FASEB J. 2015;29:2315–26.
pubmed: 25681462
pmcid: 4447222
doi: 10.1096/fj.14-268409
Howie D, Cobbold SP, Adams E, Ten Bokum A, Necula AS, Zhang W, et al. Foxp3 drives oxidative phosphorylation and protection from lipotoxicity. JCI Insight. 2017;2:e89160.
pubmed: 28194435
pmcid: 5291728
doi: 10.1172/jci.insight.89160
Chen YB, Aon MA, Hsu YT, Soane L, Teng X, McCaffery JM, et al. Bcl-xL regulates mitochondrial energetics by stabilizing the inner membrane potential. J Cell Biol. 2011;195:263–76.
pubmed: 21987637
pmcid: 3198165
doi: 10.1083/jcb.201108059
Angelin A, Gil-de-Gomez L, Dahiya S, Jiao J, Guo L, Levine MH, et al. Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments. Cell Metab. 2017;25:1282–93 e1287.
pubmed: 28416194
pmcid: 5462872
doi: 10.1016/j.cmet.2016.12.018
Galgani M, De Rosa V, La Cava A, Matarese G. Role of metabolism in the immunobiology of regulatory T cells. J Immunol. 2016;197:2567–75.
pubmed: 27638939
pmcid: 5027986
doi: 10.4049/jimmunol.1600242
Clambey ET, McNamee EN, Westrich JA, Glover LE, Campbell EL, Jedlicka P, et al. Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa. Proc Natl Acad Sci USA. 2012;109:E2784–2793.
pubmed: 22988108
doi: 10.1073/pnas.1202366109
Dang EV, Barbi J, Yang HY, Jinasena D, Yu H, Zheng Y, et al. Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell. 2011;146:772–84.
pubmed: 21871655
pmcid: 3387678
doi: 10.1016/j.cell.2011.07.033
Shi LZ, Wang R, Huang G, Vogel P, Neale G, Green DR, et al. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J Exp Med. 2011;208:1367–76.
pubmed: 21708926
pmcid: 3135370
doi: 10.1084/jem.20110278
Teh CE, Daley SR, Enders A, Goodnow CC. T-cell regulation by casitas B-lineage lymphoma (Cblb) is a critical failsafe against autoimmune disease due to autoimmune regulator (Aire) deficiency. Proc Natl Acad Sci USA. 2010;107:14709–14.
pubmed: 20668237
doi: 10.1073/pnas.1009209107
pmcid: 20668237